A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
Lenacapavir, a Long-acting injectable drug used to prevent HIV, will be made available for $40 a year in over 120 low- and middle-income countries, under a new agreement announced this week between ...
Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...
Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...
Globally, over half of people living with HIV are women. But in clinical cure trials, they make up only about 20% of ...
Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.
AZoLifeSciences on MSN
Discovery of R-Loops Reveals Key Vulnerability in HIV-1 Life Cycle
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...
AllAfrica on MSN
Are There HIV Meds in the Water? Here's What the Science Says
An old research report turned up in the headlines last month and left South Africans worried about our water systems. Bhekisisa joined up with Africa Check to find out how good research got ...
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...
The impact of the US slashing foreign aid on the country’s Mpox response has likely been huge, activists on the ground tell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results